News

SOUTH SAN FRANCISCO, Calif., May 05, 2026 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac...

Orchestra BioMed Press Release NEW HOPE, Pa., April 30, 2026 -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic...

Mass General Brigham Press Release Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person’s inherited risk for eight...

iRhythm Holdings Press Release SAN FRANCISCO, April 27, 2026 -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today announced results from two real-world retrospective analyses in post-ablation and pregnancy patient populations presented...

A minimally invasive heart procedure may be a better first-line treatment than medication for people living with advanced forms of atrial fibrillation, according to a major international clinical trial led by researchers at the UBC Faculty of...

 Heart Rhythm Society Press Release CHICAGO, IL, APRIL 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation (ULTA) may offer a promising new treatment option for patients...

HRS Press Release CHICAGO, IL, APRIL 26, 2026 – New results from the multicenter Catheter Ablation versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT) trial show that catheter ablation may reduce ventricular tachycardia...

HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)

Abbott Press Release ABBOTT PARK, Ill., April 25, 2026 -- Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction...

HRS Press Release CHICAGO, IL, APRIL 24, 2026 – A new analysis from the NOAH – AFNET 6 trial shows that artificial intelligence (AI) can help unlock data from pacemakers to better understand stroke risk in patients with...